sözaltı news Finance
Finance
EN AZ
Drug developer ADARx seeks $1.74 billion valuation in US IPO

Drug developer ADARx seeks $1.74 billion valuation in US IPO

finance.yahoo.com 21.09.2026 19:00 7 views